One Step Closer To An Artificial Nerve Cell

Main Category: Neurology / Neuroscience
Also Included In: IT / Internet / E-mail;  Medical Devices / Diagnostics;  Hearing / Deafness
Article Date: 08 Jul 2009 - 6:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Scientists at the Swedish medical university Karolinska Institutet and Linköping University are well on the way to creating the first artificial nerve cell that can communicate specifically with nerve cells in the body using neurotransmitters. The technology has been published in an article in Nature Materials.

The methods that are currently used to stimulate nerve signals in the nervous system are based on electrical stimulation. Examples of this are cochlear implants, which are surgically inserted into the cochlea in the inner ear, and electrodes that are used directly in the brain. One problem with this method is that all cell types in the vicinity of the electrode are activated, which gives undesired effects.

Scientists have now used an electrically conducting plastic to create a new type of "delivery electrode" that instead releases the neurotransmitters that brain cells use to communicate naturally. The advantage of this is that only neighbouring cells that have receptors for the specific neurotransmitter, and that are thus sensitive to this substance, will be activated.

The scientists demonstrate in the article in Nature Materials that the delivery electrode can be used to control the hearing function in the brains of guinea pigs.

"The ability to deliver exact doses of neurotransmitters opens completely new possibilities for correcting the signalling systems that are faulty in a number of neurological disease conditions", says Professor Agneta Richter-Dahlfors who has led the work, together with Professor Barbara Canlon.

The scientists intend to continue with the development of a small unit that can be implanted into the body. It will be possible to program the unit such that the release of neurotransmitters takes place as often or as seldom as required in order to treat the individual patient. Research projects that are already under way are targeted towards hearing, epilepsy and Parkinson's disease.

The research is being carried out in collaboration between the research groups of Professor Agneta Richter-Dahlfors and Professor Barbara Canlon, together with Professor Magnus Berggren's group at Linköping University. The work falls under the auspices of the Center of Excellence in Organic Bioelectronics, financed by the Swedish Foundation for Strategic Research and led by Magnus Berggren and Agneta Richter-Dahlfors.

Publication: "Organic electronics for precise delivery of neurotransmitters to modulate mammalian sensory function", Daniel T. Simon, Sindhulakshmi Kurup, Karin C. Larsson, Ryusuke Hori, Klas Tybrandt, Michel Goiny, Edwin W. H. Jager, Magnus Berggren, Barbara Canlon and Agneta Richter-Dahlfors, Nature Materials, Advance Online Publication, 5 June 2009.

Source:
Sabina Bossi
Karolinska Institutet